Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of tuberculosis and HIV co-treatment in Africa
PACTR2009040001261177Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label trial of efavirenz in human immunodeficiency virus infection (HIV), Tuberculosis (TB) and HIV-associated tuberculosis (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Virologic success. Started Jan 2008; status: recruiting.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)HIV-associated tuberculosis
Beyond the preview
Go deeper on PACTR2009040001261177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2009040001261177.